August 18, 2025
157
3
1.91%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
3:46Now PlayingOn this episode of Stock Movers:
- Novo Nordisk (NVO) shares rise after news that it's slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx Holdings Inc. to offer it at the same price at US pharmacies.
- GoodRX (GDRX) shares surge on news Novo Nordisk is slashing the cost of Ozempic and partnering with GoodRx to offer it at US pharmacies.
- CVS (CVS) shares gain after UBS upgraded the drugstore chain to buy from neutral. Analyst Kevin Caliendo writes that the upgrade follows “two strong consecutive quarters of execution and early signs that the Healthcare Benefits (HCB) segment fixes are on track.”
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Novo Nordisk Rises, GoodRX Surges, CVS Gains on UBS Upgrade
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.